Related Experiment Video
Updated: Oct 2, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Bilateral Panuveitis with Occlusive Vasculitis following Coronavirus Disease 2019 Vaccination
Mélanie Hébert1, Simon Couture1, Isabelle Schmit1
1Department of Ophthalmology, Hôpital du Saint-Sacrement, Chu de Québec - Université Laval, Quebec City, Canada.
Purpose:
To report a case of bilateral panuveitis and occlusive vasculitis following COVID-19 vaccination.
Study Design:
Case report.
Results:
A 41-year-old otherwise healthy male presented with progressive vision loss and floaters starting 48 hours after a first dose of COVID-19 vaccine. Examination initially showed bilateral anterior uveitis, but this evolved into bilateral panuveitis with occlusive vasculitis despite topical corticosteroids over two weeks. The patient underwent extensive testing for other etiologies which were excluded. He was successfully treated with a gradual taper of topical and systemic corticosteroids leading to improvement of signs and symptoms. Follow-up is maintained for observation of avascular zones with possible neovascularization which could require laser as needed.
Conclusions:
The temporal association between vaccine and presentation makes this a plausible etiology. This remains a rare adverse event, but clinicians should be aware of this possibility to include it in their differential diagnosis when confronted with idiosyncratic ocular presentations.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Pericarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pericarditis II: Clinical Features and Diagnostic Tests
Glaucoma: Overview

